Pieris Pharmaceuticals In...

NASDAQ: PIRS · Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 10:00 PM

Pieris Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.43M -24.54M -33.28M -45.74M
Depreciation & Amortization
n/a 1.78M 2.78M 2.37M
Stock-Based Compensation
830K 3.35M 4.4M 5.21M
Other Working Capital
n/a -11.9M -26.54M 19.55M
Other Non-Cash Items
n/a -22.5M -467K -30K
Deferred Income Tax
n/a -4.52M n/a n/a
Change in Working Capital
n/a -7.38M -33.37M 30.52M
Operating Cash Flow
-10.84M -53.82M -59.93M -7.66M
Capital Expenditures
n/a -171K -1.04M -949K
Cash Acquisitions
n/a -12.17M 20.2M n/a
Purchase of Investments
n/a -22.84M -48.4M n/a
Sales Maturities Of Investments
n/a 35.01M 28.2M n/a
Other Investing Acitivies
n/a 12.17M -20.2M n/a
Investing Cash Flow
n/a 12M -21.24M -949K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
87.09M 19.8M 292K 2.03M
Financial Cash Flow
87.09M 19.8M 7.21M 59.13M
Net Cash Flow
76.25M -21.24M -79.13M 47.33M
Free Cash Flow
-10.84M -53.99M -60.97M -8.61M